Volume 16, Issue 4 e202200274
RESEARCH ARTICLE

Detection of pathological response of axillary lymph node metastasis after neoadjuvant chemotherapy in breast cancer using multiphoton microscopy

Zhonghua Han

Zhonghua Han

Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, China

Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, China

Breast Cancer Institute, Fujian Medical University, Fuzhou, China

Search for more papers by this author
Xingxin Huang

Xingxin Huang

Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory for Photonics Technology, Fujian Normal University, Fuzhou, China

Search for more papers by this author
Deyong Kang

Deyong Kang

Department of Pathology, Fujian Medical University Union Hospital, Fuzhou, China

Search for more papers by this author
Fangmeng Fu

Fangmeng Fu

Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, China

Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, China

Breast Cancer Institute, Fujian Medical University, Fuzhou, China

Search for more papers by this author
Shichao Zhang

Shichao Zhang

Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory for Photonics Technology, Fujian Normal University, Fuzhou, China

Search for more papers by this author
Zhenlin Zhan

Zhenlin Zhan

Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory for Photonics Technology, Fujian Normal University, Fuzhou, China

Search for more papers by this author
Jianxin Chen

Jianxin Chen

Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory for Photonics Technology, Fujian Normal University, Fuzhou, China

Search for more papers by this author
Lianhuang Li

Corresponding Author

Lianhuang Li

Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory for Photonics Technology, Fujian Normal University, Fuzhou, China

Correspondence

Lianhuang Li, Fujian Normal University, Fuzhou 350007, China.

Email: [email protected]

Chuan Wang, Fujian Medical University Union Hospital, Fuzhou 350001, China.

Email: [email protected]

Search for more papers by this author
Chuan Wang

Corresponding Author

Chuan Wang

Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, China

Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, China

Breast Cancer Institute, Fujian Medical University, Fuzhou, China

Correspondence

Lianhuang Li, Fujian Normal University, Fuzhou 350007, China.

Email: [email protected]

Chuan Wang, Fujian Medical University Union Hospital, Fuzhou 350001, China.

Email: [email protected]

Search for more papers by this author
First published: 12 December 2022

Abstract

Neoadjuvant treatment is often considered in breast cancer patients with axillary lymph node involvement, but most of patients do not have a pathologic complete response to therapy. The detection of residual nodal disease has a significant impact on adjuvant therapy recommendations which may improve survival. Here, we investigate whether multiphoton microscopy (MPM) could identify the pathological changes of axillary lymphatic metastasis after neoadjuvant chemotherapy in breast cancer. And furthermore, we find that there are obvious differences in seven collagen morphological features between normal node and residual axillary disease by combining with a semi-automatic image processing method, and also find that there are significant differences in four collagen features between the effective and no-response treatment groups. These research results indicate that MPM may help estimate axillary treatment response in the neoadjuvant setting and thereby tailor more appropriate and personalized adjuvant treatments for breast cancer patients.image

CONFLICT OF INTEREST

The authors declare that they have no conflict of interest.

DATA AVAILABILITY STATEMENT

No data

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.